American Journal of Transplantation

Papers
(The H4-Index of American Journal of Transplantation is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
OFC 23rd Winter Symposium320
AJT Digest for Patients: Their Own Window into Key Research303
Dual Kidney Transplantation from Extended Marginal Donors in the United States: An analysis of SRTR and Literature Review281
Benefits Of Preemptive Transplantation In Older Patients with High KDPI Kidneys: Is Sooner Better Than Later?276
Are we closer to abandoning protocol graft biopsies after pediatric liver transplantation?210
Optimization of donor flow matching and portal modulation to decrease small for size syndrome in Living Donor Liver Transplant - A Single Center American Experience205
Deceased Kidney Donors on Dialysis Create Opportunities for Renal Transplantation: A Single Center Experience198
Outcomes By Epstein-Barr Virus Serostatus In Pediatric Kidney Transplantation187
Induction of fetomaternal tolerance? Suppressing B cells!142
Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case report132
De novo membranous nephropathy in a pig-to-baboon kidney xenograft: A new xenograft glomerulopathy130
Pediatric cardiac xenotransplantation and stakeholder engagement129
Increasing Azole-resistant environmental Aspergillus fumigatus in Denmark119
Phage-display immunoprecipitation for precision mapping the autoreactome117
Will the flu vaccine work this year?115
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients114
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept114
Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates112
OPTN/SRTR 2021 Annual Data Report: COVID-19110
New metrics to measure OPO performance are here: How do we ensure organizations receive feedback and improve organ donation?109
Kaposi sarcoma herpesvirus inflammatory cytokine syndrome—a severe complication of an overlooked donor-derived infection105
Accurate eplet identification is necessary for accurate risk assessment104
Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study100
Short- and long-term complications after living donor ileal resection94
Alloantibodies after simultaneous liver-kidney transplant: A story of primary nonfunction, retransplantation, and antibody-mediated rejection94
Rethinking Lactate’s Role as a Post-Transplant Outcome Predictor During Normothermic Machine Perfusion: Science or Speculation?93
Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first report91
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation83
International multicenter study of ultralow graft-to-recipient weight ratio grafts in adult living donor liver transplantation82
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave79
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients76
DCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain75
Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation74
Navigating challenges in recipient selection for end-chain kidneys74
First case of rapidly fatal mpox from secondary (household) transmission in a kidney transplant recipient68
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-202068
Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience68
Polymicrobial bacteremia in a heart transplant recipient: More than what meets the eye68
Impact of interleukin-6 on T cells in kidney transplant recipients67
Pure laparoscopic donor hepatectomy: Experience of 556 cases at Seoul National University Hospital67
Development of a natural language processing algorithm to extract social determinants of health from clinician notes66
Long-term outcomes after normothermic machine perfusion in liver transplantation—Experience at a single North American center66
Dynamic impact of liver allocation policy change on donor utilization65
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-1965
The benefit to waitlist patients in a national paired kidney exchange program: Exploring characteristics of chain end living donor transplants65
Disparities in liver transplantation: One size may not fit all65
Validation of a novel donor lung scoring system based on the updated lung Composite Allocation Score64
An ethical analysis of conditional and partially directed live kidney donation among strangers—The Israeli experience63
Outside Front Cover63
OPTN/SRTR 2021 Annual Data Report: Lung62
Generating strategies for a national comeback in pancreas transplantation: A Delphi survey and US conference report62
Rejection and graft vasculopathy secondary to effects of Crohn's disease in a heart-transplanted child62
The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients61
Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study60
Corrigendum to ‘Partial Bladder Transplantation with En Bloc Kidney Transplant—The First Case Report of a ‘Bladder Patch Technique’ in a Human’ [American Journal of Transplantation 8 (2008) 1060-1063]58
A plan to save lives: Hong Kong–mainland China second-tier mutual assistance allocation57
Increasing liver organ acquisition fees and the risk of a tragedy of the commons56
0.10969400405884